Tectonic Therapeutic, Inc. (TECX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $410.15M
Last updated: Nov 17, 2026 at 4:10 PM ET
Tectonic Therapeutic, Inc. (TECX) Statistics
Tectonic Therapeutic (TECX) has a market cap of $410.15M and an enterprise value of $175.48M. It holds $234.67M more cash than debt, 57.22% of its market cap. Its share count is up 5.30% from a year earlier.
Total Valuation
Enterprise value is 57.22% below the market cap, as cash exceeds debt.
| Market Cap | $410.15M |
|---|---|
| Enterprise Value | $175.48M |
| Latest price (Nov 17, 2026) | $20.08 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 8.31% over 52 weeks and trades 12.31% below its 50-day average.
| Beta (1Y) | 1.04 |
|---|---|
| 52-Week Change | +8.31% |
| 1-Month Change | -5.06% |
| 3-Month Change | -45.79% |
| 6-Month Change | -26.42% |
| 5-Year Change | -70.68% |
| Total Return (1Y) | +8.31% |
| Total Return (3Y CAGR) | +9.06% |
| Total Return (5Y CAGR) | -18.71% |
| Return vs SPY (1Y) | -1.71% |
| Max Drawdown (1Y) | -49.96% |
| Max Drawdown (3Y) | -73.25% |
| Sharpe Ratio (1Y) | 0.13 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $22.90 |
| 200-Day Average | $28.13 |
| 52-Week Range | $16.77 to $39.53 |
| RSI (14 Days) | 40.9 |
| Average Volume (20 Days) | 185.73K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 19.71x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 19.71x |
|---|---|
| Quick Ratio | 19.71x |
| Debt / Equity | 0.00x |
| Interest Coverage | -3220.67x |
Returns and Efficiency
Return on equity is -38.42% and return on assets is -36.13% over the last 12 months.
| Return on Equity (ROE) | -38.42% |
|---|---|
| Return on Assets (ROA) | -36.13% |
| ROA (5Y Average) | -67.07% |
| ROIC (5Y Average) | -33.48% |
Scores
TECX has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$96.49M |
| Pretax Income | -$62.53M |
| Net Income | -$88.10M |
| Reported EPS (TTM) | -$4.63 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 94.04% of the $243.86M in total assets.
| Cash and Equivalents | $234.67M |
|---|---|
| Total Debt | $0 |
| Net Cash | $234.67M |
| Net Cash Per Share | $11.91 |
| Working Capital | $226.45M |
| Shareholder Equity | $229.32M |
| Book Value Per Share | $11.64 |
| Total Assets | $243.86M |
| Total Liabilities | $14.54M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$69.23M |
|---|---|
| FCF Per Share | -$3.55 |
| Depreciation and Amortization | $2.10M |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
TECX does not pay a dividend.
| Buyback Yield | 0.00% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-12 reverse split on Jun 21, 2024.
| Last Split Date | Jun 21, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:12 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About TECX
What is TECX's market cap?
Tectonic Therapeutic has a market cap of $410.15M. Its enterprise value, which adds debt and subtracts cash, is $175.48M.
How many shares of TECX are outstanding?
Tectonic Therapeutic has 19.70M shares outstanding. The count is up 5.30% from a year earlier.
Does TECX pay a dividend?
No. Tectonic Therapeutic does not pay a dividend.
How much debt does TECX have?
Tectonic Therapeutic has $0 of total debt and $234.67M of cash and equivalents, a net cash position of $234.67M.
TECX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors